http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102770554-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06 |
| filingDate | 2010-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102770554-B |
| titleOfInvention | Antibody glycosylation variant |
| abstract | The present invention relates to Fc sequence and other evaluations containing the molecule of Fc of antagonist.In Fc district, have the antibody of glycosylated versions and other molecule displays containing Fc go out and improve the resistance of proteolytic enzyme, described proteases is as stomach en-, plasmin, trypsinase, Quimotrase, matrix metalloproteinase, serine endopeptidase and L-Cysteine HCL Anhydrous.The described molecule containing Fc can be used for treating various disease and illness. |
| priorityDate | 2009-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1835.